Hansen, J Paul <br/><br/>
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Mar 2002 
 - 1093-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.300.3.1093  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biological Transport--drug effects<br/>Body Temperature--drug effects<br/>Cell Membrane--drug effects<br/>Cocaine--analogs & derivatives<br/>Dopamine--metabolism<br/>Dopamine Plasma Membrane Transport Proteins<br/>Dopamine Uptake Inhibitors--toxicity<br/>Hallucinogens--toxicity<br/>Kinetics<br/>Male<br/>Membrane Glycoproteins--biosynthesis<br/>Membrane Transport Proteins--biosynthesis<br/>Methamphetamine--toxicity<br/>N-Methyl-3,4-methylenedioxyamphetamine--toxicity<br/>Nerve Tissue Proteins<br/>Neuropeptides<br/>Neurotoxins--toxicity<br/>Rats<br/>Rats, Sprague-Dawley<br/>Synaptic Vesicles--drug effects<br/>Tetrabenazine--analogs & derivatives<br/>Vesicular Biogenic Amine Transport Proteins<br/>Vesicular Monoamine Transport Proteins